Temedica
Latest round
- Series B
Last raised
- Aug 2022
Total raised
- $44M
Investors
- 5
About Temedica
Temedica GmbH is a German company specializing in AI-driven solutions that enhance commercialization for pharmaceutical firms.Founded in 2016 and headquartered in Munich, Germany, Temedica GmbH focuses on providing AI-powered solutions for the pharmaceutical sector. The company was established by Gloria Seibert, Pd Friedrich, and Tom Feuerstein.Temedica specializes in AI-powered solutions aimed at enhancing the commercialization efforts of pharmaceutical companies. Their core offerings include the Permea Insight Hub, Permea Disease Navigator, and Patient Companion, which collectively facilitate real-world insights, patient engagement, and data-driven decision-making. These products are designed to address challenges such as optimizing brand performance, improving patient adherence, and generating real-world evidence to inform medical and commercial strategies. The client base primarily consists of pharmaceutical companies looking to refine their marketing, sales, and patient engagement strategies.Temedica generates revenue through a multi-faceted transaction structure involving B2B partnerships with pharmaceutical companies. Clients typically engage with Temedica through subscription agreements for access to their suite of AI-driven tools and insights. This allows pharmaceutical companies to leverage real-time data for market analysis, patient journey mapping, and adherence solutions. Specific pricing structures for these services are tailored to the individual needs of the clients, based on the complexity and scope of the projects undertaken. The company plans to introduce new products aimed at enhancing patient engagement and real-world insights, though specific release dates have not been disclosed. Temedica is targeting expansion into additional European and North American markets to increase its reach within the pharmaceutical industry.
Who invested in Temedica
5 investors across 2 rounds
See all investors in Temedica
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Temedica
Who invested in Temedica?
Temedica has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Temedica raised?
Temedica has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Temedica last raise money?
Temedica's most recent round on record is a Series B, in Aug 2022.
What does Temedica do?
Temedica GmbH is a German company specializing in AI-driven solutions that enhance commercialization for pharmaceutical firms.
Where is Temedica headquartered?
Temedica is headquartered in Munich, Germany.
Which VCs invest in companies like Temedica?
Among active investors with capital left to deploy, Index Ventures, European Investment Bank, Highland Europe and Balderton Capital back software companies at Temedica's stage. Their profiles are linked below.
VCs backing software startups at Series B
Raising like Temedica? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.